12:00 AM
 | 
Mar 08, 1999
 |  BC Week In Review  |  Company News  |  Deals

Cytel, Baxter Healthcare Corp. deal

Baxter's Nextran Inc. unit (Princeton, N.J.) received an exclusive license to CYTL's Sugar Nucleotide Cycling Technology to...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >